Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
1984-10-12
pubmed:abstractText
L-alanosine is an antitumor compound which has recently entered clinical trials. Single i.p. doses of this drug inhibit antibody production to thymus-dependent and thymus-independent antigens as well as delayed hypersensitivity to SRBC in mice. Moreover, the in vitro lymphoproliferative responses of splenocytes to Concanavalin A and bacterial Lipopolysaccharides are also affected when the drug is added upon setting up the cultures. On the other hand, in vivo treatment with L-alanosine does not impair spleen natural killer (NK) activity. The results are discussed in an effort to characterize the immuno-suppressive activity of L-alanosine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0163-0571
pubmed:author
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
25-41
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed-meshheading:6470495-Alanine, pubmed-meshheading:6470495-Animals, pubmed-meshheading:6470495-Antibiotics, Antineoplastic, pubmed-meshheading:6470495-Antibody Formation, pubmed-meshheading:6470495-Cells, Cultured, pubmed-meshheading:6470495-Cytotoxicity, Immunologic, pubmed-meshheading:6470495-Cytotoxicity Tests, Immunologic, pubmed-meshheading:6470495-Erythrocytes, pubmed-meshheading:6470495-Female, pubmed-meshheading:6470495-Hypersensitivity, Delayed, pubmed-meshheading:6470495-Killer Cells, Natural, pubmed-meshheading:6470495-Lymphocyte Activation, pubmed-meshheading:6470495-Male, pubmed-meshheading:6470495-Mice, pubmed-meshheading:6470495-Mice, Inbred C57BL, pubmed-meshheading:6470495-Mitogens, pubmed-meshheading:6470495-Neoplasms, Experimental, pubmed-meshheading:6470495-Sheep, pubmed-meshheading:6470495-Spleen
pubmed:year
1984
pubmed:articleTitle
Effect of L-alanosine on immune response.
pubmed:publicationType
Journal Article